Skip to main content
Type at least 3 characters

1,702 articles

Original Research

Published on 27 Nov 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

in Thoracic Oncology

  • Zachary D. Wallen
  • Mary K. Nesline
  • Marni Tierno
  • Alison Roos
  • Erica Schnettler
  • Hatim Husain
  • Pratheesh Sathyan
  • Brian Caveney
  • Marcia Eisenberg
  • Eric A. Severson
Frontiers in Oncology
doi 10.3389/fonc.2024.1473327
  • 1,569 views